Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001696EBVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS10017407HBVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS30009529HIVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS30009530HIVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS30068820HIVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS30068821HIVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS30068822HIVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS30068823HIVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS30068824HIVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TVIS20031100HPVENSG00000077782.23protein_codingFGFR1YesNo2260A0A0S2Z3Q6
P11362
TCGA Plot Options
Drug Information
GeneFGFR1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0002131
UniProt IDP11362
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830